Calithera Biosciences, Inc.
Calithera Biosciences, Inc. (CALA) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · CALA · as of Dec 31, 2022
Ownership Breakdown
1
Institutional Holders
▲ 1 vs Q3
$7
Total Inst. Value
▲ $7 vs Q3
4.87M
Shares Outstanding
freeFloat 99.07%
2
13F Shares Held
▲ 2 vs Q3
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
CALA largest shareholders · institutional ownership
Q4 2022 · SEC 13F
Showing top 1 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
QUENT CAPITAL, LLC pharmaceutical preparations | 2 | 0.00% | 0.00% | $7,000 | Jan 19, 2023 | NEW |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q4 2022 vs prior quarter
Q4 2022
0
Increased
+0 shares1
New Positions
first time holders0
Decreased
−0 shares0
Sold Out
fully exitedNet shares change (top 50)
+0
+0 / −0
Net new holders
+1
1 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
CALA insider trading · insider activity
Source: SEC Form 4
Insiders have been primarily selling shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.
0
Buy transactions
6
Sell transactions
0.00
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
TAKEDA PHARMACEUTICAL CO LTD | Apr 17, 2023 | J-Other | 1,000,000 | $40.08 | $40.08M | 0 | Form 4 ↗ |
PAKIANATHAN DEEPIKA director | Jan 27, 2023 | Sale | 1,172 | $0.39 | $452.158 | 0 | Form 4 ↗ |
Sjogren Eric SR. VP, DRUG DISCOVERY | Jan 23, 2023 | Tax Withhold | 279 | $0.45 | $124.462 | 8.5K | Form 4 ↗ |
Kuriakose Emil CHIEF MEDICAL OFFICER | Jan 23, 2023 | Tax Withhold | 79 | $0.45 | $35.242 | 3.5K | Form 4 ↗ |
Molineaux Susan PRESIDENT & CEO | Jan 23, 2023 | Tax Withhold | 526 | $0.45 | $234.649 | 27.9K | Form 4 ↗ |
Wong Stephanie See Remarks | Jan 23, 2023 | Tax Withhold | 317 | $0.45 | $141.414 | 6.3K | Form 4 ↗ |
Molineaux Christopher SR. VP, DEVELOPMENT | Jan 23, 2023 | Tax Withhold | 217 | $0.45 | $96.804 | 27.9K | Form 4 ↗ |
Takeda Ventures, Inc.
| Jul 1, 2022 | J-Other | 1,000,000 | — | — | 1.00M | Form 4 ↗ |
TAKEDA PHARMACEUTICAL CO LTD 10 percent owner | Jul 1, 2022 | J-Other | 1,000,000 | $40.08 | $40.08M | 1.00M | Form 4 ↗ |
Takeda Ventures, Inc.
| Jul 1, 2022 | J-Other | 1,000,000 | — | — | 0 | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Calithera Biosciences, Inc. (CALA) is primarily owned by institutional investors, who hold approximately 0.0% of total shares outstanding. Company insiders own approximately 0.93%, while retail and public investors account for the remaining 99.07%.
The largest institutional shareholder of Calithera Biosciences, Inc. is QUENT CAPITAL, LLC, holding approximately 2 shares — equal to — of outstanding shares — as of December 31, 2022.
A total of 1 institutional investors currently hold CALA stock, with a combined institutional value of approximately $7 as of the most recent 13F filing period.
Frequently asked questions
CALA ownershipCalithera Biosciences, Inc. (CALA) is primarily owned by institutional investors, who hold approximately 0.0% of shares. The largest shareholder is QUENT CAPITAL, LLC with a — stake. Company insiders hold 0.93%. Data sourced from SEC Form 13F as of December 31, 2022.